FI902391A0 - Nya derivat av basisk maennisko/bovin -fibroblast-vaextfaktor. - Google Patents

Nya derivat av basisk maennisko/bovin -fibroblast-vaextfaktor.

Info

Publication number
FI902391A0
FI902391A0 FI902391A FI902391A FI902391A0 FI 902391 A0 FI902391 A0 FI 902391A0 FI 902391 A FI902391 A FI 902391A FI 902391 A FI902391 A FI 902391A FI 902391 A0 FI902391 A0 FI 902391A0
Authority
FI
Finland
Prior art keywords
derivatives
bfgf
vaextfaktor
maennisko
basisk
Prior art date
Application number
FI902391A
Other languages
English (en)
Inventor
Laura Bergonzoni
Antonella Isacchi
Paolo Sarmientos
Gilles Cauet
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI902391A0 publication Critical patent/FI902391A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eye Examination Apparatus (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI902391A 1988-09-16 1990-05-14 Nya derivat av basisk maennisko/bovin -fibroblast-vaextfaktor. FI902391A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888821795A GB8821795D0 (en) 1988-09-16 1988-09-16 New derivatives of human/bovine basic fibroplast growth factor
PCT/EP1989/001075 WO1990002800A1 (en) 1988-09-16 1989-09-15 New derivatives of human/bovine basic fibroblast growth factor

Publications (1)

Publication Number Publication Date
FI902391A0 true FI902391A0 (fi) 1990-05-14

Family

ID=10643728

Family Applications (1)

Application Number Title Priority Date Filing Date
FI902391A FI902391A0 (fi) 1988-09-16 1990-05-14 Nya derivat av basisk maennisko/bovin -fibroblast-vaextfaktor.

Country Status (21)

Country Link
EP (2) EP0363675B1 (fi)
JP (1) JP2888575B2 (fi)
KR (1) KR900702027A (fi)
CN (1) CN1041181A (fi)
AT (1) ATE98693T1 (fi)
AU (1) AU620925B2 (fi)
CA (1) CA1340834C (fi)
DE (1) DE68911461T2 (fi)
DK (1) DK120290A (fi)
ES (1) ES2061855T3 (fi)
FI (1) FI902391A0 (fi)
GB (1) GB8821795D0 (fi)
HU (1) HUT53937A (fi)
IL (1) IL91615A0 (fi)
MY (1) MY104910A (fi)
NO (1) NO902176L (fi)
NZ (1) NZ230621A (fi)
PT (1) PT91719B (fi)
WO (1) WO1990002800A1 (fi)
YU (1) YU179489A (fi)
ZA (1) ZA897020B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143829A (en) * 1990-03-29 1992-09-01 California Biotechnology Inc. High level expression of basic fibroblast growth factor having a homogeneous n-terminus
US5478804A (en) * 1990-09-19 1995-12-26 The Salk Institute For Biological Studies Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates
US6833354B1 (en) 1990-12-19 2004-12-21 Kaken Pharmaceutical Co., Ltd. Agent for the treatment of bone diseases
JP3135138B2 (ja) * 1990-12-19 2001-02-13 科研製薬株式会社 骨疾患治療剤
DE69205466T2 (de) * 1991-03-21 1996-05-30 Procter & Gamble Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten.
JP3303211B2 (ja) * 1991-04-26 2002-07-15 武田薬品工業株式会社 ｂＦＧＦムテインおよびその製造法
TW275068B (fi) * 1993-09-24 1996-05-01 American Cyanamid Co
AUPO247496A0 (en) 1996-09-23 1996-10-17 Resmed Limited Assisted ventilation to match patient respiratory need
US6214795B1 (en) * 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
FR2780416B1 (fr) * 1998-06-10 2002-12-20 Rhone Poulenc Nutrition Animal Procede industriel de production de proteines heterologues chez e. coli et souches utiles pour le procede
EP1207900A2 (en) * 1999-08-13 2002-05-29 Chiron Corporation Dose of an angiogenic factor and method of administering to improve myocardial blood flow
DE69933057T2 (de) * 1999-12-22 2007-03-15 Ortho-Mcneil Pharmaceutical, Inc. Analoge des humanen basischen fibroblasten-wachstumsfactors
CA2430112C (en) 2000-11-27 2010-07-27 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and use thereof
WO2013090919A1 (en) * 2011-12-16 2013-06-20 Wisconsin Alumni Research Foundation Fgf-2 having enhanced stability
CN106957359B (zh) * 2016-08-31 2020-04-24 黄志锋 Fgf1突变体及其医药应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81839A0 (en) * 1986-03-14 1987-10-20 Takeda Chemical Industries Ltd Polypeptide,dna and its use
AU1185488A (en) * 1987-01-16 1988-08-10 Amgen, Inc. Production of fibroblast growth factor
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
JP2879148B2 (ja) * 1987-07-07 1999-04-05 サイオス インコーポレイテッド 組換え繊維芽細胞成長因子
EP0326907A1 (en) * 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA and its use

Also Published As

Publication number Publication date
DE68911461D1 (de) 1994-01-27
WO1990002800A1 (en) 1990-03-22
EP0363675A1 (en) 1990-04-18
NZ230621A (en) 1992-06-25
EP0396664A1 (en) 1990-11-14
ZA897020B (en) 1990-08-29
ATE98693T1 (de) 1994-01-15
NO902176L (no) 1990-07-13
DK120290A (da) 1990-07-16
MY104910A (en) 1994-06-30
HU895573D0 (en) 1990-11-28
YU179489A (en) 1991-10-31
CA1340834C (en) 1999-11-30
IL91615A0 (en) 1990-04-29
AU4317189A (en) 1990-04-02
DE68911461T2 (de) 1994-05-19
GB8821795D0 (en) 1988-10-19
PT91719B (pt) 1995-05-31
AU620925B2 (en) 1992-02-27
EP0363675B1 (en) 1993-12-15
PT91719A (pt) 1990-03-30
DK120290D0 (da) 1990-05-15
JPH03501855A (ja) 1991-04-25
JP2888575B2 (ja) 1999-05-10
KR900702027A (ko) 1990-12-05
ES2061855T3 (es) 1994-12-16
NO902176D0 (no) 1990-05-15
HUT53937A (en) 1990-12-28
CN1041181A (zh) 1990-04-11

Similar Documents

Publication Publication Date Title
FI902391A0 (fi) Nya derivat av basisk maennisko/bovin -fibroblast-vaextfaktor.
NO974812L (no) Nytt protein og fremgangsmåte for fremstilling av dette
ATE114169T1 (de) Morphogenetisches knochenprotein.
DE3750197D1 (de) Antagonisten des Fibroblasten-Wachstumsfaktors.
DK0643767T3 (da) Osteogene peptider
DK0458959T3 (da) Hidtil ukendte blodpladeafledte vækstfaktor B-kædeanaloger og fremgangsmåde til homogen fremstilling deraf
HU9200548D0 (en) Improved activity process of recombined proteins
ATE108458T1 (de) Immunglobulin-e-kompetitor.
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
DK38889D0 (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0276778A3 (en) High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
ATE82329T1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
ATE131175T1 (de) Protein mit fibroblasten-wachstumsfaktor- rezeptoraktivität.
DE58909261D1 (de) Ancrod-proteine, ihre herstellung und verwendung.
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
DE3900770A1 (de) Verfahren zur herstellung von pdgf-a und pdgf-aa
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
Bergonzoni et al. Deletion mutant of basic fibroblast growth factor and production thereof

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: FARMITALIA CARLO ERBA S.R.L